Russell Investments Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Russell Investments Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-37,900	Closed	-$7.98K	–	3668
2023 Q2	$7.98K	Hold	37,900	–	–	﹤0.01%	3013
2023 Q1	$6.06K	Hold	37,900	–	–	﹤0.01%	2935
2022 Q4	$21K	Hold	37,900	–	–	﹤0.01%	2794
2022 Q3	$45K	Hold	37,900	–	–	﹤0.01%	2753
2022 Q2	$23K	Hold	37,900	–	–	﹤0.01%	2789
2022 Q1	$43K	Hold	37,900	–	–	﹤0.01%	2635
2021 Q4	$85K	Hold	37,900	–	–	﹤0.01%	2855
2021 Q3	$129K	Hold	37,900	–	–	﹤0.01%	2848
2021 Q2	$113K	Sell	37,900 -31,635	-45%	-$100K	﹤0.01%	3037
2021 Q1	$223K	Buy	69,535 +31,457	+83%	+$105K	﹤0.01%	2791
2020 Q4	$79K	Sell	38,078 -5,331	-12%	-$8.79K	﹤0.01%	2883
2020 Q3	$50K	Sell	43,409 -42	-0.1%	-$43	﹤0.01%	3078
2020 Q2	$39K	Buy	43,451 +17,051	+65%	+$16.3K	﹤0.01%	3007
2020 Q1	$21K	Sell	26,400 -1,800	-6%	-$2.09K	﹤0.01%	2950
2019 Q4	$26K	Sell	28,200 -100	-0.4%	-$110	﹤0.01%	3025
2019 Q3	$29K	Sell	28,300 -1,000	-3%	-$1.36K	﹤0.01%	2956
2019 Q2	$53K	Buy	29,300 +6,400	+28%	+$10.3K	﹤0.01%	2726
2019 Q1	$43K	Buy	22,900 +5,700	+33%	+$8.34K	﹤0.01%	2814
2018 Q4	$21K	Buy	+17,200	New	+$30.9K	﹤0.01%	2861
2018 Q2	–	Sell	-28,000	Closed	-$59K	–	2983
2018 Q1	$59K	Sell	28,000 -12,900	-32%	-$27.7K	﹤0.01%	2815
2017 Q4	$91K	Sell	40,900 -1,800	-4%	-$3.73K	﹤0.01%	2794
2017 Q3	$57K	Sell	42,700 -56,400	-57%	-$70K	﹤0.01%	2842
2017 Q2	$155K	Sell	99,100 -109,138	-52%	-$210K	﹤0.01%	2736
2017 Q1	$673K	Buy	208,238 +166,138	+395%	+$409K	﹤0.01%	2305
2016 Q4	$59K	Buy	+42,100	New	+$55K	﹤0.01%	2958

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Russell Investments Group's INFI Position: Q3 2023 in Review

Russell Investments Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 37,900 shares — an estimated $7.98K sold.

Russell Investments Group first reported a position in INFI in Q4 2016 and held it in 25 quarters. The position peaked at $673K in Q1 2017. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Russell Investments Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Russell Investments Group sold 37,900 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $7.98K.
Russell Investments Group first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2016 and held it in 25 quarters.
Russell Investments Group's Infinity Pharmaceuticals, Inc. position peaked at $673K in Q1 2017.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Russell Investments Group's 13F filing for Q3 2023, filed 13 Nov 2023.